Spots Global Cancer Trial Database for A Randomized Trial to Assess the Role of Imaging During Follow up After Radical Surgery of High Risk Melanoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Randomized Trial to Assess the Role of Imaging During Follow up After Radical Surgery of High Risk Melanoma

Official Title: A Prospective Randomized Multicenter Trial to Assess the Role of Imaging During Follow up After Radical Surgery of Stage IIb-c and III Cutaneous Malignant Melanoma

Study ID: NCT03116412

Conditions

Malignant Melanoma

Interventions

CT or PET scans

Study Description

Brief Summary: It is not known whether radiological assessments during follow up after surgery for high risk melanoma improve survival. Since radiological examinations are resource demanding, could inflict worry and cause irradiation exposure it is an important question to address. With the introduction of effective medical treatments for malignant melanoma patients, there is a tendency to introduce radiological assessments despite the lack of evidence.

Detailed Description: The patients are randomized 1:1 to routine follow up for 3 years with regular doctors´ appointments according to national guidelines and the same follow up but with the addition of whole body CT or Positron Emission Tomography (PET) scans and blood tests.